arrow left
arrow right
  • Dan Albasry as Trustee of the Estate of Newal Al Saad, Firas Mohammad v. Barretts Minerals Inc., Beacon Cmp Corp., Brenntag North America Inc. (Individually And As Successor To Minerals And Pigment Solutions Inc., Successor To Whittaker, Clark & Daniels Inc.);, Brenntag Specialties Llc (Individually And As Successor To Minerals And Pigment Solutions Inc., Successor To Whittaker, Clark & Daniels Inc.);, Charles B. Chrystal Company Inc.;, Colgate Palmolive Co.;, Glaxosmithkline Consumer Healthcare Holdings (Us) Llc (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Glaxosmithkline Llc (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Gsk Consumer Health Inc. (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Lornamead Inc. (Individually And As Successor To Lornamead Acquisitions Ltd. And Lornamead Brands Inc., D/B/A Yardley Of London A/K/A Yardley);, Pfizer Inc., Port Jervis Laboratories Inc. (F/K/A Kolmar Laboratories Inc.);, The Procter & Gamble Co. (Individually, D/B/A, And As Successor To Yardley Of London Ltd., Yardley Of London A/K/A Yardley, Yardley Of London Inc., And Yardley Of London (U.S.) Llc));, Whittaker, Clark & Daniels Inc. (Individually, D/B/A, And Successor To Charles Mathieu Inc. (D/B/A Charles Mathieu & Co. And Chas. Mathieu Inc.), American Talc Company Inc., Metropolitan Talc Company Inc., Imperial Products Co. Inc., And Resource Processo, Yardley Of London Inc. (F/K/A Lentheric Inc. And Lentheric Distributors Inc.);, Yardley Of London Ltd.,, Conopco Inc. (Individually, Doing Business As, And As Successor To Elizabeth Arden Inc. And Evyan Perfumes Inc., Parfums International And Idea Fragrances Co.)Torts - Asbestos document preview
  • Dan Albasry as Trustee of the Estate of Newal Al Saad, Firas Mohammad v. Barretts Minerals Inc., Beacon Cmp Corp., Brenntag North America Inc. (Individually And As Successor To Minerals And Pigment Solutions Inc., Successor To Whittaker, Clark & Daniels Inc.);, Brenntag Specialties Llc (Individually And As Successor To Minerals And Pigment Solutions Inc., Successor To Whittaker, Clark & Daniels Inc.);, Charles B. Chrystal Company Inc.;, Colgate Palmolive Co.;, Glaxosmithkline Consumer Healthcare Holdings (Us) Llc (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Glaxosmithkline Llc (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Gsk Consumer Health Inc. (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Lornamead Inc. (Individually And As Successor To Lornamead Acquisitions Ltd. And Lornamead Brands Inc., D/B/A Yardley Of London A/K/A Yardley);, Pfizer Inc., Port Jervis Laboratories Inc. (F/K/A Kolmar Laboratories Inc.);, The Procter & Gamble Co. (Individually, D/B/A, And As Successor To Yardley Of London Ltd., Yardley Of London A/K/A Yardley, Yardley Of London Inc., And Yardley Of London (U.S.) Llc));, Whittaker, Clark & Daniels Inc. (Individually, D/B/A, And Successor To Charles Mathieu Inc. (D/B/A Charles Mathieu & Co. And Chas. Mathieu Inc.), American Talc Company Inc., Metropolitan Talc Company Inc., Imperial Products Co. Inc., And Resource Processo, Yardley Of London Inc. (F/K/A Lentheric Inc. And Lentheric Distributors Inc.);, Yardley Of London Ltd.,, Conopco Inc. (Individually, Doing Business As, And As Successor To Elizabeth Arden Inc. And Evyan Perfumes Inc., Parfums International And Idea Fragrances Co.)Torts - Asbestos document preview
  • Dan Albasry as Trustee of the Estate of Newal Al Saad, Firas Mohammad v. Barretts Minerals Inc., Beacon Cmp Corp., Brenntag North America Inc. (Individually And As Successor To Minerals And Pigment Solutions Inc., Successor To Whittaker, Clark & Daniels Inc.);, Brenntag Specialties Llc (Individually And As Successor To Minerals And Pigment Solutions Inc., Successor To Whittaker, Clark & Daniels Inc.);, Charles B. Chrystal Company Inc.;, Colgate Palmolive Co.;, Glaxosmithkline Consumer Healthcare Holdings (Us) Llc (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Glaxosmithkline Llc (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Gsk Consumer Health Inc. (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Lornamead Inc. (Individually And As Successor To Lornamead Acquisitions Ltd. And Lornamead Brands Inc., D/B/A Yardley Of London A/K/A Yardley);, Pfizer Inc., Port Jervis Laboratories Inc. (F/K/A Kolmar Laboratories Inc.);, The Procter & Gamble Co. (Individually, D/B/A, And As Successor To Yardley Of London Ltd., Yardley Of London A/K/A Yardley, Yardley Of London Inc., And Yardley Of London (U.S.) Llc));, Whittaker, Clark & Daniels Inc. (Individually, D/B/A, And Successor To Charles Mathieu Inc. (D/B/A Charles Mathieu & Co. And Chas. Mathieu Inc.), American Talc Company Inc., Metropolitan Talc Company Inc., Imperial Products Co. Inc., And Resource Processo, Yardley Of London Inc. (F/K/A Lentheric Inc. And Lentheric Distributors Inc.);, Yardley Of London Ltd.,, Conopco Inc. (Individually, Doing Business As, And As Successor To Elizabeth Arden Inc. And Evyan Perfumes Inc., Parfums International And Idea Fragrances Co.)Torts - Asbestos document preview
  • Dan Albasry as Trustee of the Estate of Newal Al Saad, Firas Mohammad v. Barretts Minerals Inc., Beacon Cmp Corp., Brenntag North America Inc. (Individually And As Successor To Minerals And Pigment Solutions Inc., Successor To Whittaker, Clark & Daniels Inc.);, Brenntag Specialties Llc (Individually And As Successor To Minerals And Pigment Solutions Inc., Successor To Whittaker, Clark & Daniels Inc.);, Charles B. Chrystal Company Inc.;, Colgate Palmolive Co.;, Glaxosmithkline Consumer Healthcare Holdings (Us) Llc (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Glaxosmithkline Llc (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Gsk Consumer Health Inc. (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Lornamead Inc. (Individually And As Successor To Lornamead Acquisitions Ltd. And Lornamead Brands Inc., D/B/A Yardley Of London A/K/A Yardley);, Pfizer Inc., Port Jervis Laboratories Inc. (F/K/A Kolmar Laboratories Inc.);, The Procter & Gamble Co. (Individually, D/B/A, And As Successor To Yardley Of London Ltd., Yardley Of London A/K/A Yardley, Yardley Of London Inc., And Yardley Of London (U.S.) Llc));, Whittaker, Clark & Daniels Inc. (Individually, D/B/A, And Successor To Charles Mathieu Inc. (D/B/A Charles Mathieu & Co. And Chas. Mathieu Inc.), American Talc Company Inc., Metropolitan Talc Company Inc., Imperial Products Co. Inc., And Resource Processo, Yardley Of London Inc. (F/K/A Lentheric Inc. And Lentheric Distributors Inc.);, Yardley Of London Ltd.,, Conopco Inc. (Individually, Doing Business As, And As Successor To Elizabeth Arden Inc. And Evyan Perfumes Inc., Parfums International And Idea Fragrances Co.)Torts - Asbestos document preview
  • Dan Albasry as Trustee of the Estate of Newal Al Saad, Firas Mohammad v. Barretts Minerals Inc., Beacon Cmp Corp., Brenntag North America Inc. (Individually And As Successor To Minerals And Pigment Solutions Inc., Successor To Whittaker, Clark & Daniels Inc.);, Brenntag Specialties Llc (Individually And As Successor To Minerals And Pigment Solutions Inc., Successor To Whittaker, Clark & Daniels Inc.);, Charles B. Chrystal Company Inc.;, Colgate Palmolive Co.;, Glaxosmithkline Consumer Healthcare Holdings (Us) Llc (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Glaxosmithkline Llc (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Gsk Consumer Health Inc. (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Lornamead Inc. (Individually And As Successor To Lornamead Acquisitions Ltd. And Lornamead Brands Inc., D/B/A Yardley Of London A/K/A Yardley);, Pfizer Inc., Port Jervis Laboratories Inc. (F/K/A Kolmar Laboratories Inc.);, The Procter & Gamble Co. (Individually, D/B/A, And As Successor To Yardley Of London Ltd., Yardley Of London A/K/A Yardley, Yardley Of London Inc., And Yardley Of London (U.S.) Llc));, Whittaker, Clark & Daniels Inc. (Individually, D/B/A, And Successor To Charles Mathieu Inc. (D/B/A Charles Mathieu & Co. And Chas. Mathieu Inc.), American Talc Company Inc., Metropolitan Talc Company Inc., Imperial Products Co. Inc., And Resource Processo, Yardley Of London Inc. (F/K/A Lentheric Inc. And Lentheric Distributors Inc.);, Yardley Of London Ltd.,, Conopco Inc. (Individually, Doing Business As, And As Successor To Elizabeth Arden Inc. And Evyan Perfumes Inc., Parfums International And Idea Fragrances Co.)Torts - Asbestos document preview
  • Dan Albasry as Trustee of the Estate of Newal Al Saad, Firas Mohammad v. Barretts Minerals Inc., Beacon Cmp Corp., Brenntag North America Inc. (Individually And As Successor To Minerals And Pigment Solutions Inc., Successor To Whittaker, Clark & Daniels Inc.);, Brenntag Specialties Llc (Individually And As Successor To Minerals And Pigment Solutions Inc., Successor To Whittaker, Clark & Daniels Inc.);, Charles B. Chrystal Company Inc.;, Colgate Palmolive Co.;, Glaxosmithkline Consumer Healthcare Holdings (Us) Llc (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Glaxosmithkline Llc (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Gsk Consumer Health Inc. (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Lornamead Inc. (Individually And As Successor To Lornamead Acquisitions Ltd. And Lornamead Brands Inc., D/B/A Yardley Of London A/K/A Yardley);, Pfizer Inc., Port Jervis Laboratories Inc. (F/K/A Kolmar Laboratories Inc.);, The Procter & Gamble Co. (Individually, D/B/A, And As Successor To Yardley Of London Ltd., Yardley Of London A/K/A Yardley, Yardley Of London Inc., And Yardley Of London (U.S.) Llc));, Whittaker, Clark & Daniels Inc. (Individually, D/B/A, And Successor To Charles Mathieu Inc. (D/B/A Charles Mathieu & Co. And Chas. Mathieu Inc.), American Talc Company Inc., Metropolitan Talc Company Inc., Imperial Products Co. Inc., And Resource Processo, Yardley Of London Inc. (F/K/A Lentheric Inc. And Lentheric Distributors Inc.);, Yardley Of London Ltd.,, Conopco Inc. (Individually, Doing Business As, And As Successor To Elizabeth Arden Inc. And Evyan Perfumes Inc., Parfums International And Idea Fragrances Co.)Torts - Asbestos document preview
  • Dan Albasry as Trustee of the Estate of Newal Al Saad, Firas Mohammad v. Barretts Minerals Inc., Beacon Cmp Corp., Brenntag North America Inc. (Individually And As Successor To Minerals And Pigment Solutions Inc., Successor To Whittaker, Clark & Daniels Inc.);, Brenntag Specialties Llc (Individually And As Successor To Minerals And Pigment Solutions Inc., Successor To Whittaker, Clark & Daniels Inc.);, Charles B. Chrystal Company Inc.;, Colgate Palmolive Co.;, Glaxosmithkline Consumer Healthcare Holdings (Us) Llc (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Glaxosmithkline Llc (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Gsk Consumer Health Inc. (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Lornamead Inc. (Individually And As Successor To Lornamead Acquisitions Ltd. And Lornamead Brands Inc., D/B/A Yardley Of London A/K/A Yardley);, Pfizer Inc., Port Jervis Laboratories Inc. (F/K/A Kolmar Laboratories Inc.);, The Procter & Gamble Co. (Individually, D/B/A, And As Successor To Yardley Of London Ltd., Yardley Of London A/K/A Yardley, Yardley Of London Inc., And Yardley Of London (U.S.) Llc));, Whittaker, Clark & Daniels Inc. (Individually, D/B/A, And Successor To Charles Mathieu Inc. (D/B/A Charles Mathieu & Co. And Chas. Mathieu Inc.), American Talc Company Inc., Metropolitan Talc Company Inc., Imperial Products Co. Inc., And Resource Processo, Yardley Of London Inc. (F/K/A Lentheric Inc. And Lentheric Distributors Inc.);, Yardley Of London Ltd.,, Conopco Inc. (Individually, Doing Business As, And As Successor To Elizabeth Arden Inc. And Evyan Perfumes Inc., Parfums International And Idea Fragrances Co.)Torts - Asbestos document preview
  • Dan Albasry as Trustee of the Estate of Newal Al Saad, Firas Mohammad v. Barretts Minerals Inc., Beacon Cmp Corp., Brenntag North America Inc. (Individually And As Successor To Minerals And Pigment Solutions Inc., Successor To Whittaker, Clark & Daniels Inc.);, Brenntag Specialties Llc (Individually And As Successor To Minerals And Pigment Solutions Inc., Successor To Whittaker, Clark & Daniels Inc.);, Charles B. Chrystal Company Inc.;, Colgate Palmolive Co.;, Glaxosmithkline Consumer Healthcare Holdings (Us) Llc (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Glaxosmithkline Llc (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Gsk Consumer Health Inc. (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Lornamead Inc. (Individually And As Successor To Lornamead Acquisitions Ltd. And Lornamead Brands Inc., D/B/A Yardley Of London A/K/A Yardley);, Pfizer Inc., Port Jervis Laboratories Inc. (F/K/A Kolmar Laboratories Inc.);, The Procter & Gamble Co. (Individually, D/B/A, And As Successor To Yardley Of London Ltd., Yardley Of London A/K/A Yardley, Yardley Of London Inc., And Yardley Of London (U.S.) Llc));, Whittaker, Clark & Daniels Inc. (Individually, D/B/A, And Successor To Charles Mathieu Inc. (D/B/A Charles Mathieu & Co. And Chas. Mathieu Inc.), American Talc Company Inc., Metropolitan Talc Company Inc., Imperial Products Co. Inc., And Resource Processo, Yardley Of London Inc. (F/K/A Lentheric Inc. And Lentheric Distributors Inc.);, Yardley Of London Ltd.,, Conopco Inc. (Individually, Doing Business As, And As Successor To Elizabeth Arden Inc. And Evyan Perfumes Inc., Parfums International And Idea Fragrances Co.)Torts - Asbestos document preview
						
                                

Preview

FILED: NEW YORK COUNTY CLERK 07/10/2023 10:29 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 166 RECEIVED NYSCEF: 07/10/2023 EXHIBIT 81 FILED: NEW YORK COUNTY CLERK 07/10/2023 10:29 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 166 RECEIVED NYSCEF: 07/10/2023 FILED: NEW YORK COUNTY CLERK 07/10/2023 10:29 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 166 RECEIVED NYSCEF: 07/10/2023 FILED: NEW YORK COUNTY CLERK 07/10/2023 10:29 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 166 RECEIVED NYSCEF: 07/10/2023 FILED: NEW YORK COUNTY CLERK 07/10/2023 10:29 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 166 RECEIVED NYSCEF: 07/10/2023 National Trends Driving Asbestos Litigation September 14, 2022 Prepared for the Perrin Conferences National Asbestos Litigation Conference Do not duplicate or distribute without written permission from KCIC. FILED: NEW YORK COUNTY CLERK 07/10/2023 10:29 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 166 RECEIVED NYSCEF: 07/10/2023 About KCIC Megan Burns (née Shockley) burnsm@kcic.com Managing Director Do not duplicate or distribute without written permission from KCIC. FILED: NEW YORK COUNTY CLERK 07/10/2023 10:29 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 166 RECEIVED NYSCEF: 07/10/2023 What is in the Data? K KCIC utilizes only the publicly available data The average contained in complaints for analyses contained c time between filing and KCIC’s iin our annual Asbestos Litigation Year in Review processing is rreports and related presentations. one month 2022 Filings To Date 2,191 Lawsuits received through 8/28 ~114 Jurisdictions & Plaintiff Firms 68 Defendants per Lawsuit (average) Do not duplicate or distribute without written permission from KCIC. FILED: NEW YORK COUNTY CLERK 07/10/2023 10:29 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 166 RECEIVED NYSCEF: 07/10/2023 National Trends | Filings (received through 8/28/22) 2018 2019 2020 2021 2022* 4,147 4,144 3,783 3,818 3,707 Total Filings Total Filings Total Filings Total Filings Total Filings 7.1% 0.1% 8.7% 0.9% 2.9% Decrease Decrease Decrease Increase Decrease 2017 to 2018 2018 to 2019 2019 to 2020 2020 to 2021 2021 to 2022* change in change in change in change in change in filings filings filings filings filings * Estimation of 2022 full year total. Jan 1 – Aug 28th Avg # of 2021 2,320 59% complaints received by 8/28 2022 2,191 Do not duplicate or distribute without written permission from KCIC. FILED: NEW YORK COUNTY CLERK 07/10/2023 10:29 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 166 RECEIVED NYSCEF: 07/10/2023 Disease | Filing Trends by Disease Lung cancer filings had the most significant shift in filings trends by disease so far for 2022 – projected 14% decrease. +3% -14% +8% Mesothelioma Lung Cancer Non-Malignant * Estimation of 2022 full year total. Do not duplicate or distribute without written permission from KCIC. FILED: NEW YORK COUNTY CLERK 07/10/2023 10:29 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 166 RECEIVED NYSCEF: 07/10/2023 Disease| Disease Mix MESOTHELIOMA LUNG CANCER While the mesothelioma percentage share OTHER CANCER has increased slightly 2018-2022, Total mesothelioma cases were less than UNKNOWN/NOT STATED total mesothelioma cases in 2018. NON-MALIGNANT Do not duplicate or distribute without written permission from KCIC. FILED: NEW YORK COUNTY CLERK 07/10/2023 10:29 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 166 RECEIVED NYSCEF: 07/10/2023 Jurisdiction | Concentration Top 15 Jurisdictions – 2022 YTD Filing Concentration by State – 2022 YTD -3% +21% +25% -21% -30% -21% 3%, +3% 3%, +70% 3%, -8% 4%, -32% 6%, +31% 1–20 Filings Emerging 7%, +59% 21–99 Filings 7%, +4% Dissipating 100–200 Filings 12%, -32% 200–299 Filings 300+ Filings Do not duplicate or distribute without written permission from KCIC. FILED: NEW YORK COUNTY CLERK 07/10/2023 10:29 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 166 RECEIVED NYSCEF: 07/10/2023 Jurisdiction | Notable Increases Wayne, Michigan gan g • Total Filings: 59% increase in filings vs 8/28/2021 //2021 • Already 85% of 2021 total • Non-malignant: 104% increase vs 8/28/2021 //2021 • Already 97% of 2021 total Philadelphia, Phila d Pennsylvania a • Total Tota a Filings: 31% increase vs 8/28/2021 • Already 69% of 2021 total • Mess Mesothelioma: 57% increase; Lung Cancer 24% increase vs 8/28/21 • Mesothelioma: already 78% off 2021 total; l Lung Cancer: C 66% Los Angeles, California fornia • Total Filings: 70% increase vs 8/28/2021 /28/2021 • Already 101% of 2021 0 021 total • Mesothelioma: 58% increase vs 8/28/2021 /28/2021 • Already 102% of 2021 0 021 total Do not duplicate or distribute without written permission from KCIC. FILED: NEW YORK COUNTY CLERK 07/10/2023 10:29 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 166 RECEIVED NYSCEF: 07/10/2023 Jurisdiction | Nota Notable Decreases Notab St. Clair, IIllinois • Total Filings: Filin 32% decrease vs 8/28/2021 • Only On y 41% of 2021 total • can Lung cancer: 30% decrease in filings vs 8/28/2021 On y 43% of 2021 total • Only 3% St. Louis, M Missouri Meso: • Total Filings: 32% decrease vs vs 8/28/2021 24% • Only 44% off 2021 total • Lung Cancer: 36% decrease vs 8/28/21 Lung • Only 44% off 2021 total Cancer: 73% Kanawha, Kanawha a West Virginia • Total Filings: Filin n 30% decrease vs 8/28/2021 On 43% of 2021 total • Only • Lung Cancer: Can n 44% decrease vs 8/28/2021 On 35% of 2021 total • Only Do o not duplicate or distribute without written permission per perm from KCIC. FILED: NEW YORK COUNTY CLERK 07/10/2023 10:29 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 166 RECEIVED NYSCEF: 07/10/2023 Mesothelioma & Lung Cancer | National Trends Top States for Mesothelioma & Lung Cancer 2020-2022 Mesothelioma: 1. Illinois (50%) 2. New York (10%) 3. California (8%) 4. Pennsylvania (7%) 5. New Jersey (4%) Lung Cancer: 1. Illinois (49%) 2. New York (12%) 3. Missouri (10%) MESOTHELIOMA 4. Pennsylvania (8%) 5. Delaware (5%) LUNG CANCER Do not duplicate or distribute without written permission from KCIC. FILED: NEW YORK COUNTY CLERK 07/10/2023 10:29 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 166 RECEIVED NYSCEF: 07/10/2023 Mesothelioma | Top Jurisdictions Madison County mesothelioma filings decreased 7%, mesothelioma filings in the top jurisdictions increased 2%. +11% +58% -2% *Data as of 8/28 each year. Do not duplicate or distribute without written permission from KCIC. FILED: NEW YORK COUNTY CLERK 07/10/2023 10:29 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 166 RECEIVED NYSCEF: 07/10/2023 Lung Cancer | Top Jurisdicitions Compared to the same time last year, St. Clair lung cancer filings have decreased 18%. -30% Madison No change St. Louis -36% NYCAL -15% Philadelphia +24% *Data *D t as off 8/28 each h year. Do not duplicate or distribute without written permission from KCIC. FILED: NEW YORK COUNTY CLERK 07/10/2023 10:29 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 166 RECEIVED NYSCEF: 07/10/2023 You can download KCIC’s 2021 Asbestos Report at: https://www.kcic.com/asbestos Megan Burns burnsm@kcic.com Thank You! www.kcic.com Managing Director FILED: NEW YORK COUNTY CLERK 07/10/2023 10:29 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 166 RECEIVED NYSCEF: 07/10/2023 National Verdict Trends in Asbestos Litigation 2022 National Asbestos Litigation Conference ©2022 Perrin Conferences LLC. All rights reserved. The views are shared for educational purposes only and provided for use only in connection with this event. FILED: NEW YORK COUNTY CLERK 07/10/2023 10:29 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 166 RECEIVED NYSCEF: 07/10/2023 Asbestos Cases Reaching Verdict Year Number of Filings* Number of Verdicts % of Cases Reaching Verdicts 2015 5,336 48 0.90% 2016 4,829 45 0.93% 2017 4,463 34 0.76% 2018 4,147 40 0.96% 2019 4,144 39 0.94% 2020 3,783 10 0.26% 2021 3,818 21 0.55% 2022 2,191** 12 0.55% ™ Less than 1% of cases filed were tried to verdict. ™ Trial proceedings in 2020-2021 were significantly impacted by COVID-19 pandemic. *Filing data provided by KCIC. ** Figure current through 8/28/2022. FILED: NEW YORK COUNTY CLERK 07/10/2023 10:29 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 166 RECEIVED NYSCEF: 07/10/2023 60 50 Total Asbestos 40 Verdicts 30 2015 -2022 20 10 0 2015 2016 2017 2018 2019 2020 2021 2022 FILED: NEW YORK COUNTY CLERK 07/10/2023 10:29 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 166 RECEIVED NYSCEF: 07/10/2023 Verdicts Are Split Year Plaintiff Defendant Total % P-D 2015 26 22 48 54-46 2016 24 21 45 53-47 2017 20 14 34 59-41 2018 23 17 40 58-42 2019 29 10 39 74-26 2020 9 1 10 90-10 2021 15 6 21 71-29 2022 11 1 12 92-8 Total 157 92 249 63-37 FILED: NEW YORK COUNTY CLERK 07/10/2023 10:29 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 166 RECEIVED NYSCEF: 07/10/2023 Verdict Awards Vary Significantly – Influenced By Talc Total* Damages Awarded: 2015-2022 Asbestos Talc $1,000,000,000 $900,000,000 $800,000,000 $700,000,000 $600,000,000 $500,000,000 $400,000,000 $300,000,000 $200,000,000 $100,000,000 $0 2015 2016 2017 2018 2019 2020 2021 2022 *2018 figure does not include the extreme outlier $4.69 billion ovarian cancer verdict from St. Louis, MO. *2019 – includes $217M award including punitives from New Jersey talc verdict. *2020 – includes $186M award including punitives from New Jersey talc verdict. FILED: NEW YORK COUNTY CLERK 07/10/2023 10:29 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 166 RECEIVED NYSCEF: 07/10/2023 Total Damages Awarded: More Than Six Billion* 2018 2019 3 Plaintiffs Verdicts: Totaling $4.8 Billion 4 Plaintiffs Verdicts – Totaling $406.7 Million Talc Verdicts & 3 Defense Verdicts 4 Defense Verdicts Mistrials 4 Mistrials 2018-2021 2020 2021 2 Plaintiffs Verdicts – 3 Plaintiffs Verdicts – Totaling $195 Million Totaling $107.3 Million 1 Mistrial 4 Defense Verdicts * Includes $4.7 Billion St. Louis Verdict in 2018 – Ingham v. J & J FILED: NEW YORK COUNTY CLERK 07/10/2023 10:29 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 166 RECEIVED NYSCEF: 07/10/2023 Since 2015, 57% of all asbestos verdicts have occurred in five states: CA NY PA LA FL 18 69 in California: • San Francisco Co. 16 • Los Angeles Co. • Alameda Co. 14 12 26 in New York: • NYCAL 10 8 18 in Pennsylvania: • Philadelphia 6 12 in Louisiana: 4 • Orleans Parish 2 15 in Florida: 0 • Miami Dade 2015 2016 2017 2018 2019 2020 2021 2022 FILED: NEW YORK COUNTY CLERK 07/10/2023 10:29 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 166 RECEIVED NYSCEF: 07/10/2023 2022 Verdict Highlights 2022 Plaintiffs’ verdicts average $18.8 Million – nearly matching 2021 average of $19 Million. Living mesothelioma plaintiff awarded $36.7 Million by jury in Orleans Parrish, Louisiana. A St. Louis, Missouri, jury awarded a mesothelioma plaintiff’s wife $10 Million for loss of consortium, for a total verdict of $20 Million. Jury in Newcastle, Delaware returned a verdict in favor of defense. FILED: NEW YORK COUNTY CLERK 07/10/2023 10:29 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 166 RECEIVED NYSCEF: 07/10/2023 Average Annual Defense Costs for Asbestos-Related Claims 2015-2021 5 Year Average Total Spend Pre-Pandemic 2020 Costs 2021 Costs 2015-2021 Company A $77,240,000 $50,900,000 $55,200,000 $492,300,000 Company B $26,600,000 $21,000,000 $19,000,000 $173,000,000 Company C $197,200,000 $229,000,000 $240,000,000 $1,455,000,000 Company D $16,000,000 $13,000,000 $15,000,000 $108,000,000 Company E $21,400,000 $22,000,000 $23,200,000 $144,390,000 *Approximate Cost FILED: NEW YORK COUNTY CLERK 07/10/2023 10:29 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 166 RECEIVED NYSCEF: 07/10/2023 135 Most Recent https://www.crowell.com/Practices/Bankruptcy-Creditors-Rights/History-of-Asbestos-Bankruptcies FILED: NEW YORK COUNTY CLERK 07/10/2023 10:29 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 166 RECEIVED NYSCEF: 07/10/2023 Asbestos Bankruptcy Trust Transparency Laws 2017 2014 2017 2018 2017 2012 2016 2015 2018 2018 2015 2016 2013 2017 2019 2015 FILED: NEW YORK COUNTY CLERK 07/10/2023 10:29 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 166 RECEIVED NYSCEF: 07/10/2023 Asbestos Over-naming Reform Disclosure Laws 2021 2020 2021 2021 2022 FILED: NEW YORK COUNTY CLERK 07/10/2023 10:29 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 166 RECEIVED NYSCEF: 07/10/2023 National Trends Cost of Litigation Continues to Increase Bankruptcy Transparency & Over-naming Trends Impact of the Evolution of Asbestos Lawyers & Law Firms COVID & Asbestos Litigation